ÌÇÐÄÆÆ½â°æ

GSK (GlaxoSmithKline)

Statistics report about pharmaceutical company GSK

This report presents key facts and figures about the British pharmaceutical company GSK, formerly known as GlaxoSmithKline. GSK is one of the world's 10 largest pharmaceutical companies. This report shows the company's role in global pharma, its revenues, major products, expenses, etc.

Table of contents

Global positioning

5
  • Premium Statistic Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
  • Premium Statistic Leading European pharmaceutical & biotechnology companies 2026, by market cap
  • Basic Statistic Pharma company ranking based on access to medicine in developing countries 2024
  • Premium Statistic Largest M&A pharmaceutical deals ever as of 2024
  • Premium Statistic Leading therapy classes by spending global market 2028

Key facts

4
  • Premium Statistic GSK revenue 2006-2025
  • Premium Statistic GSK profit 2006-2024
  • Premium Statistic GSK number of employees by region 2011-2025
  • Basic Statistic GSK advertising spending 2011-2025

Business segments

3
  • Premium Statistic GSK's revenue 2013-2025, by region
  • Premium Statistic GSK Pharmaceuticals revenue 2025, by therapeutic area
  • Basic Statistic GSK revenue by division 2006-2024

Competitors

5
  • Premium Statistic Pfizer revenue 2006-2025
  • Basic Statistic Sanofi revenue 2006-2025
  • Premium Statistic Merck & Co. revenue 2006-2025
  • Premium Statistic AstraZeneca's total revenue 2006-2025
  • Premium Statistic Gilead Sciences revenue 2006-2024

Research and development

4
  • Premium Statistic GSK research and development expenditure 2006-2024
  • Premium Statistic Top pharma companies worldwide 2026, by size of R&D pipeline
  • Basic Statistic Top pharma companies worldwide by number of originated drugs 2026
  • Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.